Status:
COMPLETED
Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities
Lead Sponsor:
Aalborg University Hospital
Collaborating Sponsors:
Aalborg University
Conditions:
Deep Venous Thrombosis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of the study was to evaluate efficacy and safety of the new acute treatment of deep venous thrombosis by use of low-molecular-weight heparin compared with standard treatment using unfracti...
Detailed Description
Deep-venous thrombosis (DVT) remains a common clinical problem (annual incidence 0.10-0.16%) and long-term morbidity as chronic venous insufficience (CVI) in 10-30%. As to recurrent DVT, initial trea...
Eligibility Criteria
Inclusion
- First DVT with or without known risk factors except overt cancer
- Second DVT more than two years after the first if the patient was without clinical signs of CVI.
Exclusion
- Contraindication to anticoagulation therapy
- Candidate to thrombectomy with arterious-venous fistula or thrombolytic therapy
- Known cancer at the time of the DVT diagnosis
- Patients unable to cooperate for anticoagulation therapy or manage the tests.
Key Trial Info
Start Date :
October 1 1993
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2004
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT00628576
Start Date
October 1 1993
End Date
June 1 2004
Last Update
March 5 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Haematology; Aalborg Hospital
Aalborg, North Denmark, Denmark, 9000